And the appearance of aberrant glycosylation leads to the formation of new glycan epitopes and the exposure of peptide chain epitopes, which cause the tumor cell-specific antigenic epitope formation, making MUC1 a tumor-associated antigen (TAA) recognized by the immune system [70, 71]. The gene discussed is MUC1; the disease is neoplasm.